Evaluation of science advice during the COVID-19 pandemic in Sweden
Column: Did Sweden beat the pandemic by refusing to lock down? No, its record is disastrous
The effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions: a systematic literature review and meta-analysis of the latest research
Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort study
Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study
Has covid-19 become milder?
Not 'little adults': Experts say long COVID undercounted, misdiagnosed in kids | CIDRAP
SARS-CoV-2 can cause lasting damage to cells’ energy production
How COVID-19 Changes the Immune System
Postacute sequelae of COVID-19 at 2 years
Acquired Immune Deficiency Syndrome correlation with SARS-CoV-2 N genotypes
Core Mitochondrial Genes are Down-Regulated During SARS-CoV-2 Infection of Rodent and Human Hosts
Long COVID in a Highly Vaccinated Population Infected During a SARS-CoV-2 Omicron Wave
Long COVID-19 Cardiac Complications Are Associated With Autoimmunity to Cardiac Self-Antigens Sufficient to Cause Cardiac Dysfunction
As infections rise again, why are we still ignoring long COVID?
Omicron variants of SARS-CoV-2 and long COVID
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection
Long COVID Now Looks like a Neurological Disease, Helping Doctors to Focus Treatments
Should We Expect an Increase in the Number of Cancer Cases in People with Long COVID?
Kashyap Patel, MD, Sees Link Between COVID-19 and Cancer Progression, Calls for More Biomarker Testing
Possible Cancer-Causing Capacity of COVID-19: Is SARS-CoV-2 an Oncogenic Agent?
Causal Effects of COVID‐19 on Cancer Risk
PolitiFact - A claim that viruses and other pathogens always evolve to become less lethal is false
Do Bad Viruses Always Become Good Guys in the End?
Long Covid Risk: 1 in 5
Is It Time for a Reality Check on Rapid COVID Tests?
Monthly Counts of Deaths by Select Causes, 2014-2019 | Data | Centers for Disease Control and Prevention
Immunologist Akiko Iwasaki: ‘We are not done with Covid, not even close’
Rising Risks with COVID Reinfection
The Immunology of Long COVID
An extensive review of studies on Long Covid concludes, "The oncoming burden of long COVID faced by patients, health-care providers, governments and economies is so large as to be unfathomable, which is possibly why minimal high-level planning is currently allocated to it."